LAURA ELIZABETH WIEBER
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner ALTAMONTE SPRINGS, FL NPI 1013311901
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner FL NOVARTIS PHARMACEUTICALS CORPORATION All categories
General Payments — all program years on this page
$3,271.10
- Category: General Payments
- Program years: PY2022–2024
- Record count: 148
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,191.72 across 56 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,191.72 | 56 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| NOVARTIS PHARMACEUTICALS CORPORATION | $173.54 | 8 |
| Celgene Corporation | $137.51 | 6 |
| GENZYME CORPORATION | $105.49 | 5 |
| Janssen Biotech, Inc. | $69.40 | 3 |
| PFIZER INC. | $59.71 | 2 |
| Genentech USA, Inc. | $52.61 | 2 |
| TerSera Therapeutics LLC | $50.10 | 3 |
| Incyte Corporation | $48.43 | 2 |
| Acerta Pharma LLC | $44.47 | 2 |
| ABBVIE INC. | $42.07 | 2 |
| JAZZ PHARMACEUTICALS INC. | $40.08 | 2 |
| BeiGene USA, Inc. | $36.71 | 2 |
| Merck Sharp & Dohme Corporation | $29.07 | 1 |
| EMD Serono, Inc. | $28.58 | 1 |
| Lilly USA, LLC | $28.38 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $28.31 | 1 |
| Alexion Pharmaceuticals, Inc. | $24.36 | 1 |
| E.R. Squibb & Sons, L.L.C. | $24.04 | 1 |
| Rigel Pharmaceuticals, Inc. | $22.42 | 1 |
| EISAI INC. | $21.86 | 1 |
| Mirati Therapeutics, Inc. | $21.29 | 1 |
| GlaxoSmithKline, LLC. | $21.23 | 1 |
| ADC Therapeutics America, Inc. | $17.48 | 1 |
| Kyowa Kirin, Inc. | $16.33 | 1 |
| Agios Pharmaceuticals, Inc. | $15.28 | 1 |
| SERVIER PHARMACEUTICALS LLC | $14.36 | 1 |
| TAIHO ONCOLOGY, INC. | $13.45 | 1 |
| Emmaus Medical, Inc. | $5.16 | 2 |
By program year
Records — PY2024 (56)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.